Has Jianhui Zhang, MD received payments from drug or device companies?

Yes. Drug and device makers reported $12,456 in general payments to Jianhui Zhang, MD across 662 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jianhui Zhang, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jianhui Zhang, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jianhui Zhang, MD

Neurology · Lebanon, NHNPI 1417170952

Payments from drug & device makers

$12,456in general payments, 2019–2025

Across 662 payments — averaging $18.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$3K
SK Life Science, Inc.$1K
EMD Serono, Inc.$1K
Amgen$908
Genentech USA, Inc.$534
Lundbeck LLC$498
plus $6K from 38 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	206	$2,573
SK Life Science, Inc.	59	$1,117
EMD Serono, Inc.	36	$1,030
Amgen(2 entities)	40	$908
Genentech USA, Inc.	21	$534
Lundbeck LLC	31	$498
Novartis	29	$489
UCB, Inc.	19	$480
Neurocrine Biosciences, Inc.	25	$479
Biogen	18	$398
Johnson & Johnson	10	$361
Lilly USA, LLC	19	$348
Pfizer	14	$303
Argenx US, Inc.	8	$248
Eisai Inc.	11	$241
Bristol Myers Squibb	9	$185
Amneal Pharmaceuticals LLC	10	$180
Otsuka America Pharmaceutical, Inc.	8	$172
Neurelis, Inc.	7	$162
AstraZeneca(2 entities)	8	$156
GE HealthCare	5	$146
Biohaven Pharmaceutical Holding Company Ltd.	10	$144
E.r. Squibb & Sons, L.L.C.	1	$125
Teva Pharmaceuticals USA, Inc.	7	$119
Upsher-smith Laboratories LLC	6	$113
Avanir Pharmaceuticals, Inc.	4	$102
Kyowa Kirin, Inc.	5	$97
Supernus Pharmaceuticals, Inc.	5	$92
Biohaven Pharmaceuticals, Inc.	3	$78
Acadia Pharmaceuticals Inc	3	$67
MDD US Operations, LLC	3	$63
Insightec,inc	2	$50
CSL Behring	2	$46
Livanova USA, Inc.	2	$43
Scilex Pharmaceuticals Inc.	3	$42
Collegium Pharmaceutical, Inc.	2	$41
Takeda Pharmaceuticals U.S.A., Inc.	2	$39
Acorda Therapeutics, Inc	2	$33
Avion Pharmaceuticals	2	$32
Axsome Therapeutics, Inc.	1	$27
Neuropace, Inc.	1	$25
Grifols USA, LLC	1	$24
Jazz Pharmaceuticals Inc.	1	$23
Xeris Pharmaceuticals, Inc.	1	$22

How this compares

$12,456 in reported general payments places this provider in the 80th percentile of 92 neurology providers in New Hampshire.

See all neurology providers in New Hampshire →

Medicare billing

Part B allowed, 2024

$167,380

Medicare patients

342

Services billed

12,531

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Lebanon

Stephen LeeLebanon$432K
Mark GarretLebanon$270K
Andrew PachnerLebanon$210K
Elijah StommelLebanon$189K
Barbara JobstLebanon$172K
Amy ChanLebanon$84K
Oliver PhillipsLebanon$50K
Jeffrey CohenLebanon$30K
Francis BenzLebanon$8K
Thomas WardLebanon$5K

See the full list for New Hampshire →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →